Oric Pharmaceuticals Inc (ORIC)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -22.12M | -25.68M | -24.99M | -28.68M | -31.43M | -28.99M | -36.02M | -38.32M |
Pre Tax Income | -20.85M | -23.95M | -22.94M | -25.48M | -28.33M | -25.01M | -31.96M | -34.57M |
Net Income | -20.85M | -23.95M | -22.94M | -25.48M | -28.33M | -25.01M | -31.96M | -34.57M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -22.12M | -25.68M | -24.99M | -28.68M | -21.35M | -25.01M | -36.02M | -26.53M |
EBITDA | -21.87M | -25.43M | -24.73M | -28.43M | -31.17M | -28.73M | -35.75M | -38.05M |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -22.37M | -28.57M | -74.19M | -78.87M | -91.77M | -110.78M |
Pre Tax Income | -21.36M | -26.88M | -73.7M | -78.72M | -89.12M | -100.7M |
Net Income | -21.36M | -26.88M | -73.7M | -78.72M | -89.12M | -100.7M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -11.855 | -13.55 | -2.009 | -1.996 | -1.977 | -1.846 |
EBIT | -22.14M | -28.28M | -74.01M | -78.86M | -91.77M | -100.7M |
EBITDA | -21.47M | -27.54M | -73.22M | -77.97M | -90.8M | -109.75M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.